| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | -0 | 0 | 0 | -0 | -0 | -0 | -4 | -0 | -0 | 0 | 1 |
| Operating Profit % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | 0 | -4 | -0 | -0 | -0 | -4 | -0 | -0 | 0 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -0 | 0 | -4 | -0 | -0 | -0 | -4 | -0 | -0 | 0 | 1 |
| EPS in ₹ | -0.05 | -0.11 | 0.00 | -6.37 | -0.58 | -0.54 | -0.41 | -6.55 | -0.17 | -0.10 | 0.64 | 0.60 |
Bacil Pharma
Bacil Pharma
49.49
+0.94
(1.94%)
Market Cap
71.05 Cr
PE Ratio
95.20
Volume
19,940.00
Day High - Low
50.88 - 46.60
52W High-Low
51.90 - 26.69
Key Fundamentals
Market Cap
71.05 Cr
EPS
0.64
PE Ratio
95.20
PB Ratio
2.61
Book Value
18.63
EBITDA
0.40
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
1.59
Debt to Equity
0.01
Actual
Company News
View All News
Bacil Pharma Clarifies Price Movement to BSE
Feb 24, 2026
Feb 24, 2026Bacil Pharma Limited responds to BSE clarification request on February 24, 2026, stating no unpublished price sensitive information behind recent stock price movements, attributing fluctuations to market forces.
Norbexi Industries Exits Bacil Pharma StakeFeb 23, 2026
Feb 23, 2026Norbexi Industries Limited has completely divested its 14.46% stake in Bacil Pharma Limited through an off-market transaction, reducing its holding from 2,075,000 shares to zero.
Bacil Pharma reported Q3FY26 profit of ₹3.92 lakhs vs loss of ₹6.20 lakhs in Q3FY25. Nine-month profit surged to ₹72.17 lakhs from ₹38.81 lakhs YoY.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,777.10 | #1 4,26,385.82 | 38.21 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 53.49 | |
6,100.00 | 1,61,935.83 | 64.01 | 9,712.00 | 18.67 | 2,191 | -1.02 | 43.80 | |
4,270.20 | 1,44,522.97 | 62.70 | 11,539.40 | 6.99 | 1,911 | 26.24 | 50.03 | |
1,298.90 | 1,08,410.14 | 19.25 | 33,741.20 | 16.73 | 5,725 | -15.28 | 53.38 | |
2,322.50 | 1,06,091.52 | 22.06 | 22,909.50 | 13.74 | 3,306 | #1 37.44 | 56.84 | |
1,256.40 | 1,01,488.45 | 22.07 | 28,409.50 | 7.12 | 5,291 | -57.18 | 31.85 | |
890.50 | 89,605.14 | #1 17.54 | 23,511.00 | 18.55 | 4,615 | -0.32 | 45.58 | |
2,000.00 | 82,561.01 | 45.82 | 12,744.20 | #1 20.90 | 2,007 | 7.65 | 37.22 | |
1,291.40 | 75,004.72 | 20.80 | 32,345.60 | 9.43 | 3,484 | 7.59 | 60.75 | |
5,257.50 | 62,861.30 | 25.87 | 13,458.30 | 3.70 | 2,216 | 1.90 | 37.74 |
Growth Rate
Revenue Growth
600.00 %
Net Income Growth
-500.00 %
Cash Flow Change
0.40 %
ROE
-132.65 %
ROCE
-132.92 %
EBITDA Margin (Avg.)
-241.36 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 7 | 7 | 7 | 5 | 5 | 4 | 4 | 1 | 1 | 1 | 26 |
| Fixed Assets | 0 | 5 | 6 | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 |
| Current Assets | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 3 |
| Capital Work in Progress | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 21 |
| Other Assets | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 |
| Total Equity & Liabilities | 7 | 7 | 7 | 5 | 5 | 4 | 4 | 1 | 1 | 1 | 26 |
| Current Liabilities | 0 | 0 | 0 | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 7 | 6 | 6 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 25 |
| Reserve & Surplus | -0 | -0 | -0 | -4 | -5 | -5 | -5 | -5 | -5 | -5 | 12 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 14 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 3 |
| Investing Activities | -0 | -0 | 0 | -1 | 0 | 0 | 1 | 4 | -0 | 0 | 0 |
| Operating Activities | 0 | 0 | 0 | 1 | -0 | -0 | -0 | -4 | -0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 | -0 | 2 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Sept 2025 | Dec 2025 |
| Promoter | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 20.70 % | 10.60 % | 0.20 % | 0.20 % | 0.08 % | 0.08 % | 0.08 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 51.38 % | 53.85 % | 53.88 % | 52.88 % | 52.83 % | 52.90 % | 53.74 % | 53.77 % | 53.76 % | 53.79 % | 53.80 % | 53.77 % | 53.89 % | 53.91 % | 59.61 % | 67.42 % | 75.77 % | 77.37 % | 79.74 % | 80.95 % | 80.95 % |
| Others | 5.95 % | 3.48 % | 3.45 % | 4.45 % | 4.50 % | 4.43 % | 3.59 % | 3.56 % | 3.57 % | 3.54 % | 3.53 % | 3.56 % | 3.44 % | 3.42 % | 19.69 % | 21.98 % | 24.03 % | 22.43 % | 20.18 % | 18.97 % | 18.97 % |
| No of Share Holders | 0 | 6,410 | 6,319 | 6,461 | 6,514 | 6,532 | 6,545 | 6,548 | 6,649 | 6,663 | 6,647 | 6,628 | 6,770 | 6,794 | 6,902 | 7,461 | 7,638 | 7,532 | 7,541 | 7,431 | 7,431 |
Announcements
Clarification On Price MovementFeb 24, 2026
Feb 24, 2026Clarification sought from Bacil Pharma LtdFeb 24, 2026
Feb 24, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 23, 2026
Feb 23, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 23, 2026
Feb 23, 2026Revised Un-Audited Financial Result For 31St December 2025Feb 13, 2026
Feb 13, 2026Unaudited Financial Result For 31St December 2025Feb 13, 2026
Feb 13, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2026Feb 13, 2026
Feb 13, 2026Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday 13Th February 2026Feb 05, 2026
Feb 05, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 29, 2025
Dec 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 29, 2025
Dec 29, 2025Appointment of Company Secretary and Compliance OfficerDec 19, 2025
Dec 19, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 01, 2025
Dec 01, 2025Un-Audited Financial Result For 30Th September 2025Nov 13, 2025
Nov 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025Nov 13, 2025
Nov 13, 2025Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Thursday 13Th November 2025Nov 05, 2025
Nov 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Oct 14, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Sep 30, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Book Closure For The Purpose Of Annual General MeetingSep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Notice Of 38Th Annual General Meeting Of The CompanySep 05, 2025
Sep 05, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th September 2025Sep 05, 2025
Sep 05, 2025INTIMATION OF RECEIPT OF REQUEST FOR RECLASSIFICATION OF THE PROMOTER IN ACCORDANCE WITH REGULATION 31A OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015.Sep 04, 2025
Sep 04, 2025Board Meeting Intimation for We Hereby Notify You That A Meeting Of The Board Of Directors Of Bacil Pharma Limited ("The Company") Will Be Held On 05Th September 2025.Sep 02, 2025
Sep 02, 2025Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 25Th August 2025Aug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 27, 2025
Aug 27, 2025Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 25Th August 2025Aug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 25, 2025
Aug 25, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August 2025Aug 25, 2025
Aug 25, 2025Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Monday 25Th August 2025Aug 19, 2025
Aug 19, 2025Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Results Financial Results For The Quarter Ended 30/06/2025Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Results For The Quarter Ended 30/06/2025Aug 12, 2025
Aug 12, 2025We Have Recevied Query From BSE Regarding Resignation Of Mr. Prakash B. ShahAug 06, 2025
Aug 06, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August2025Aug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 22, 2025
Jul 22, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2025
Jul 18, 2025Appointment Of Ms. Chaitali Kalpataru Shah As A Executive Director And CFO Of The CompanyJul 16, 2025
Jul 16, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 16Th July 2025Jul 16, 2025
Jul 16, 2025Board Meeting Intimation for We Wish To Inform You That The Meeting Of Board Of Directors Scheduled To Be Held On Wednesday 16Th July 2025Jul 11, 2025
Jul 11, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jul 11, 2025
Jul 11, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Receipt Of Listing Approval Granted By Stock Exchange For 8463000 Equity Shares Of Rs.10/- Each Issued At A Premium Of Rs.22/- Issued To Non- Promoter On Preferential BasisJun 05, 2025
Jun 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2025
May 27, 2025Revised Audited Financial Result For The Quarter And Year Ended 31St March 2025May 26, 2025
May 26, 2025Technical Indicators
RSI(14)
Neutral 58.27
ATR(14)
Volatile 3.80
STOCH(9,6)
Neutral 53.01
STOCH RSI(14)
Neutral 26.49
MACD(12,26)
Bearish -0.27
ADX(14)
Strong Trend 29.95
UO(9)
Bearish 54.50
ROC(12)
Uptrend And Accelerating 5.50
WillR(14)
Neutral -29.43
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
